BioHealth News Archive
Life science IPOs fall in first half of 2016 – MedCity News
Summer is a good time to review investment activity for pharmaceutical and biotech companies in the year so far and a new report shows…
Read More
Roche says US FDA issues Emergency Use Authorization for Zika test – Reuters
The U.S. Food and Drug Administration on Monday issued emergency authorization for a Zika diagnostics test from Swiss drugmaker Roche, skirting normal approval channels…
Read More
Thomas Luginbill to Lead New Entrepreneur and Innovation Institute at CSM – Southern Maryland Headline News
Thomas Luginbill knows what it takes to be a successful entrepreneur. He spearheaded the founding of a campus organization when he was an undergraduate,…
Read More
AstraZeneca enters agreement with Pfizer over antibiotics portfolio
AstraZeneca announced it will sell the full commercialization and development rights of its late-stage small molecule antibiotics business to Pfizer, while AstraZeneca focuses on…
Read More
Johns Hopkins opens world’s first Zika virus center
Johns Hopkins Medicine has launched the Johns Hopkins Wilmer Zika Center, where medical professionals focus on caring for patients with the Zika virus. The…
Read More
Sofinnova Ventures has raised $595M for its largest fund to date – MedCity News
Life sciences investor Sofinnova Ventures is raising fund number 10 in what, as FierceBiotech notes, appears to be its largest fund to date. A…
Read More
10 Breakthrough Technologies 2016: DNA App Store
While driving and listening to National Public Radio one day, Justin Kao heard about the discovery of a “sweet tooth gene” that makes you…
Read More
A Tale of Two Drugs
Today’s medicines can cost hundreds of thousands of dollars a year. The story of how two companies set prices for their costly new drugs…
Read More
Roundtable: Agile Concerns for Large Organizations
Phil Magrogan, PMP, SCP4, ITIL Senior Program Manager Leidos Agile represents a widely adopted set of principles that apply to small scale teams –…
Read More
MedImmune won’t be impacted by AstraZeneca sale of antibiotic business to Pfizer – Washington Business Journal
Pharmaceutical giant AstraZeneca's agreement to sell much of its antibiotics business won't impact operations at MedImmune, its Gaithersburg-based research and development arm, officials confirmed…
Read More
SBIR Insider Updates – Aug 24, 2016
Before we start, long time readers know, we have no interest in trying to influence your political views or voting allegiance (not that we…
Read More
Hello to the New MCEDC Team and a Fond Farewell – Montgomery County Economic Development Corporation
Tans are fading, school is starting, football is about to take over our televisions, and the MCEDC is gearing up. It’s time to bring you…
Read More
How Millennial Consumers Will Transform Health Care – Knowledge@Wharton
Steve Klasko, president of Thomas Jefferson University and CEO of Jefferson Health, is the author of We Can Fix Healthcare: The Future Is Now,…
Read More
Reminder: Please Complete the Montgomery County Business Survey
In an ongoing effort to improve the experience of doing business in and/or with Montgomery County, County Executive Ike Leggett is inviting the business community to…
Read More
MedImmune won’t be impacted by AstraZeneca sale of antibiotic business to Pfizer – Baltimore Business Journal
Pharmaceutical giant AstraZeneca's agreement to sell much of its antibiotics business won't impact operations at MedImmune, its Gaithersburg-based research and development arm, officials confirmed…
Read More